KALV

Q: What is the price of KalVista Pharmaceuticals (KALV) today?

The current price of KalVista Pharmaceuticals (KALV) is $0.00. The stock began the year trading around $16.15 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does KalVista Pharmaceuticals (KALV) pay dividends?

KalVista Pharmaceuticals (KALV) did not pay dividends over the past year.

KalVista Pharmaceuticals Inc.

Price

return (12m)

0.00%

p/e

-10.93

p/bv

-75.57

DIVIDEND YIELD

0.00%

KALV price

KalVista Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KALV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals KALV

review the fundamentals of KalVista Pharmaceuticals shares

P/E

-10.93

Sector: -3.83 Industry: -3.83

P/S (PSR)

35.11

Sector: -4.25 Industry: -4.25

P/BV

-75.57

Sector: 1.93 Industry: 1.93

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-41.29%

Sector: -65.91% Industry: -65.91%

ROE

691.20%

Sector: -66.97% Industry: -66.97%

ROIC

-174.26%

Sector: -2,915.77% Industry: -2,915.77%

NET MARGIN

-100.00%

Sector: -40.24% Industry: -40.24%

GROSS MARGIN

91.30%

Sector: 36.50% Industry: 36.50%

OPERATING MARGIN

-100.00%

Sector: -39.10% Industry: -39.10%

EV/EBITDA

-12.21

Sector: -3.93 Industry: -3.93

EV/EBIT

-12.13

Sector: -4.01 Industry: -4.01

PRICE-TO-ASSETS

4.51

Sector: 1.41 Industry: 1.41

BVPS

-0.36

Sector: 1.85 Industry: 1.85

EPS

-2.47

Sector: -2.16 Industry: -2.16

EQUITY-TO-ASSETS RATIO

-0.06

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

1.06

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

17.45%

Sector: - Industry: -

Fundamentals KALV

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.15	6.78	25.92%	2.29%	$550.19 B	21.83%
PFE	19.15	1.59	8.29%	6.82%	$143.47 B	11.83%
ABBV	104.57	-57.49	-54.98%	3.14%	$380.13 B	5.79%
NVO	412.02	255.86	62.10%	4.32%	$192.14 B	37.01%
MRK	31.50	6.13	19.45%	2.92%	$281.49 B	13.59%
AZN	26.08	5.72	21.93%	1.83%	$270.97 B	17.19%
GILD	16.57	6.52	39.33%	2.59%	$152.71 B	30.99%
BMY	15.13	5.47	36.19%	4.63%	$110.05 B	15.01%
ZTS	12.57	10.27	81.75%	2.62%	$33.22 B	27.79%
REGN	14.34	2.02	14.08%	0.60%	$63.43 B	29.65%
HALO	23.19	36.83	158.82%	0.00%	$8.09 B	23.13%
AMGN	23.37	19.84	84.87%	2.90%	$182.30 B	20.96%
MCK	19.23	-109.80	-570.98%	0.42%	$91.58 B	1.18%
VRTX	26.44	5.92	22.41%	0.00%	$114.71 B	35.51%
HRMY	13.25	2.12	16.00%	0.00%	$1.93 B	16.20%
CAH	33.52	-19.50	-58.20%	0.92%	$52.12 B	0.62%
ADMA	11.86	5.02	42.37%	0.00%	$1.96 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KALV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT KalVista Pharmaceuticals

KalVista Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

22 years

Founded: 2004

2015

Time since IPO - 11 years

70

Employees

KalVista Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1,000.00 trillion, with shareholders equity totaling $-19.65 million.

The company employs approximately 70 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, KalVista Pharmaceuticals Inc. reported $42.29 million in revenue, generating net income of $-135.82 million.

Key financial metrics include a P/E ratio of -10.93, a price-to-book (P/B) ratio of -75.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker KALV.

Market cap

$1,000.00 trillion

Net worth

$-19.65 million

$-19,650,000.00

Assets

$328.92 million

$328,920,000.00

Total Shares Outstanding

55.00 million

55,000,000

Average Daily Trading Volume

$4.01 million

$4,005,637.98

Sector

Health Care

Industry

Biotechnology

KALV

KALV revenue and profits

Financial Results KALV

DRAG THE FRAME TO SEE MORE DATA

KALV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$750.63 4,53% (12M)

P/E

19.23

0.42%

ROE

-570.98%

P/BV

-109.80

CAH - Cardinal Health

$221.77 37,27% (12M)

P/E

33.52

0.92%

ROE

-58.20%

P/BV

-19.50

JNJ - Johnson & Johnson

$228.39 56,30% (12M)

P/E

26.15

2.29%

ROE

25.92%

P/BV

6.78

MRK - Merck & Co.

$113.87 49,23% (12M)

P/E

31.50

2.92%

ROE

19.45%

P/BV

6.13

AZN - AstraZeneca

$174.93 25,99% (12M)

P/E

26.08

1.83%

ROE

21.93%

P/BV

5.72

ABBV - AbbVie

$216.49 21,60% (12M)

P/E

104.57

3.14%

ROE

-54.98%

P/BV

-57.49

PFE - Pfizer

$25.21 12,55% (12M)

P/E

19.15

6.82%

ROE

8.29%

P/BV

1.59

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$750.63 4,53% (12 M)

P/L

19.23

0.42%

ROE

-570.98%

P/VP

-109.80

CAH - Cardinal Health

$221.77 37,27% (12 M)

P/L

33.52

0.92%

ROE

-58.20%

P/VP

-19.50

JNJ - Johnson & Johnson

$228.39 56,30% (12 M)

P/L

26.15

2.29%

ROE

25.92%

P/VP

6.78

MRK - Merck & Co.

$113.87 49,23% (12 M)

P/L

31.50

2.92%

ROE

19.45%

P/VP

6.13

AZN - AstraZeneca

$174.93 25,99% (12 M)

P/L

26.08

1.83%

ROE

21.93%

P/VP

5.72

ABBV - AbbVie

$216.49 21,60% (12 M)

P/L

104.57

3.14%

ROE

-54.98%

P/VP

-57.49

PFE - Pfizer

$25.21 12,55% (12 M)

P/L

19.15

6.82%

ROE

8.29%

P/VP

1.59

Frequently Asked Questions

What is the price of KalVista Pharmaceuticals (KALV) today?

The current price of KalVista Pharmaceuticals (KALV) is $0.00. The stock began the year trading around $16.15 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does KalVista Pharmaceuticals (KALV) pay dividends?

KalVista Pharmaceuticals (KALV) did not pay dividends over the past year.

Is KalVista Pharmaceuticals (KALV) a good investment?

KalVista Pharmaceuticals (KALV) is currently trading at $0.00 with a P/E ratio of -10.93. This represents a -494% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy KalVista Pharmaceuticals (KALV) stock?

You can buy KalVista Pharmaceuticals (KALV) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol KALV and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of KalVista Pharmaceuticals (KALV) yield today?

Over the past month, KalVista Pharmaceuticals (KALV) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of KalVista Pharmaceuticals (KALV) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KALV

KalVista Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KALV

review the fundamentals of KalVista Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT KalVista Pharmaceuticals

KalVista Pharmaceuticals Inc.

United States

22 years

2015

70

PROFIT X PRICE KALV

Financial Results KALV

KALV cash flow

Asset, Revenue and Profit Growth - KALV

KALV balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

PFE - Pfizer

Frequently Asked Questions